Consumer Health Cancer / Oncology
Henlius Therapy Wins Breakthrough Designation as First Immunotherapy Led Perioperative Regimen for Gastric Cancer
The first CDE-designated Breakthrough Therapy for perioperative gastric cancer, promising accelerated patient access. The world's first gastric cancer p...
November 21, 2025 | News
Abbott to Acquire Exact Sciences for $21 Billion to Transform Cancer Diagnostics
Acquisition adds a new growth vertical to Abbott's already high single-digit growth profile, gaining leadership in the fast-growing $60 billion U.S. canc...
November 21, 2025 | News
Accord BioPharma Gains FDA Approval for Two Denosumab Biosimilars to Expand Access to Osteoporosis and Cancer Related Bone Care
Products will treat osteoporosis and skeletal-related events from certain types of bone cancer, expanding the company's biosimilar portfolio Accord BioPha...
November 21, 2025 | News
Thermo Fisher FDA Clearance Expands Precision Pathway for HER2 Driven Lung Cancer Treatment
Test will serve as a companion diagnostic for Bayer’s HYRNUO™ (sevabertinib) to identify patients with NSCLC eligible for HER2-targeted therapy...
November 21, 2025 | News
Kazia Reports Initial Immune Complete Response in Stage IV Triple Negative Breast Cancer Under Expanded Access Combination Regimen
Kazia Therapeutics Limited (Nasdaq: KZIA), an oncology-focused drug development company, announced that a patient with stage IV triple-negative breast canc...
November 20, 2025 | News
Qure.ai Integrates Its Lung Cancer AI Suite into Microsoft’s Precision Imaging Network to Advance Early Diagnosis
Qure.ai, global leader in digital healthcare, announced its collaboration with Microsoft. Qure.ai will onboard its end-to-end lung cancer d...
November 20, 2025 | News
Bio Techne Licenses AI Designed NovoBody Duo Molecules Under Exclusive Agreement With Monod Bio
Partnership strengthens Bio-Techne's leadership in AI-enabled protein innovation NovoBody™ Duo molecules offer multi-specific binding capabilities...
November 19, 2025 | News
10x Genomics And ASTRA Consortium Launch Asia Pacific Pan Cancer Spatial Atlas To Advance Precision Oncology
Initiative led by researchers in Australia and Japan aims to map cancer and immune interactions to advance precision oncology across the region 10x Genomi...
November 19, 2025 | News
Debiopharm Transitions JCA Mauvernay Award Into New IDEAL Japan Programme To Drive Next Generation Oncology Research
After 20 years of the prestigious JCA (Japanese Cancer Association) Mauvernay Award in Japan, Debiopharm is now transitioning its longstanding support ...
November 19, 2025 | News
Lunit and Labcorp Partner to Advance AI-Driven Digital Pathology for Precision Oncology
Lunit, a leading provider of AI for cancer diagnostics and precision oncology, and Labcorp, a global leader of innovative and comprehensive laboratory serv...
November 18, 2025 | News
PRISM BioLab Reaches Initial Milestone in Joint Oncology Research under Agreement with Ono Pharmaceutical
PRISM BioLab, Co. Ltd. ("PRISM") announces that , PRISM and Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka; President and COO: Toichi Takino; hereinafte...
November 17, 2025 | News
Vaxcellbio and Seoul National University Partner To Develop Next Generation DDS Formulation for Macular Degeneration Therapies
Vaxcellbio (CEO Je-Jung Lee, MD, PhD ), a leading immuno-oncology company, announced that it has entered into a strategic memorandum of underst...
November 13, 2025 | News
IDT and Beckman Coulter Life Sciences Join Forces To Automate NGS Assays on the New Biomek i3 Platform
Danaher companies Integrated DNA Technologies (IDT), a global leader in genomics, and Beckman Coulter Life Sciences, a global leader in labo...
November 13, 2025 | News
SOPHiA GENETICS and Element Biosciences Partner to Merge Sequencing and AI Analytics for Precision Medicine
SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and Element Biosciences, Inc., a biology company transforming the pac...
November 12, 2025 | News
Most Read
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
